A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second‐ and third‐generation tyrosine kinase inhibitors. - Zulbaran‐Rojas, Alejandro; Lin, Huei‐Kan; Shi, Qiuling; Williams, Loretta A.; George, Binsah; Garcia‐Manero, Guillermo; Jabbour, Elias; O'Brien, Susan; Ravandi, Farhad; Wierda, William; Estrov, Zeev; Borthakur, Gautam; et al. (Cancer Medicine, 2018)